A recent article was about using “androgen derivation therapy”(ADT) to improve survival rates for men with COVID-19:
Androgens May Explain Male Vulnerability to COVID-19.
May 07, 2020
Of the entire male population of Veneto, those with cancer had an almost twofold higher risk of becoming infected with COVID-19 than men without cancer ( P < .0001).
However, when the team looked specifically at men with prostate cancer, they found “strikingly, only four out of 5273 patients receiving ADT developed SARS-CoV-2 infection and none of these patients died.”
This compared to 37,161 men with prostate cancer who were not receiving ADT, among whom 114 men developed COVID-19 and 18 died.
Among another 79,661 patients in the Veneto region with cancer other than prostate cancer, 312 developed COVID-19 and 57 died.
ADT like alpha-blockers can be used treat prostate cancer. Are they in the same class of drugs?